Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 5 of 5 entries
Sorted by: Best Match Show Resources per page
Development of acoustically isolated extracellular plasma vesicles for biomarker discovery in allogeneic hematopoietic stem cell transplantation.

Biomarker research

Lim HC, Soneji S, Pálmason R, Lenhoff S, Laurell T, Scheding S.
PMID: 33468257
Biomark Res. 2021 Jan 19;9(1):6. doi: 10.1186/s40364-020-00259-4.

BACKGROUND: Infection and graft-versus-host disease (GvHD) are the major causes for mortality and morbidity of allogeneic hematopoietic stem cell transplantation (allo-HSCT). Plasma-derived extracellular vesicles (EVs) contain disease-related proteins, DNAs and RNAs, and have recently been suggested as potential biomarker...

Cite
Lim HC, Soneji S, Pálmason R, et al. Development of acoustically isolated extracellular plasma vesicles for biomarker discovery in allogeneic hematopoietic stem cell transplantation. Biomark Res. 2021;9(1):6doi: 10.1186/s40364-020-00259-4.
Lim, H. C., Soneji, S., Pálmason, R., Lenhoff, S., Laurell, T., & Scheding, S. (2021). Development of acoustically isolated extracellular plasma vesicles for biomarker discovery in allogeneic hematopoietic stem cell transplantation. Biomarker research, 9(1), 6. https://doi.org/10.1186/s40364-020-00259-4
Lim, Hooi Ching, et al. "Development of acoustically isolated extracellular plasma vesicles for biomarker discovery in allogeneic hematopoietic stem cell transplantation." Biomarker research vol. 9,1 (2021): 6. doi: https://doi.org/10.1186/s40364-020-00259-4
Lim HC, Soneji S, Pálmason R, Lenhoff S, Laurell T, Scheding S. Development of acoustically isolated extracellular plasma vesicles for biomarker discovery in allogeneic hematopoietic stem cell transplantation. Biomark Res. 2021 Jan 19;9(1):6. doi: 10.1186/s40364-020-00259-4. PMID: 33468257; PMCID: PMC7814576.
Copy Download .nbib Format: NLM
[Assessment of health and caring needs in nursing homes. The Resident Assessment Instrument, its development and some pilot study results.].

Laeknabladid

Jonsson PV, Jensdottir AB, Gudmundsdottir H, Palsson H, Hjaltadottir I, Hardarson O, Sigurgeirsdottir S.
PMID: 19679910
Laeknabladid. 1997 Oct;83(10):640-7.

Those elderly living in institutions have multiple social, health and mental problems, in addition to loss of function. The Resident Assessment Instrument assesses the individual in detail and his caring needs. Resident Assessment Protocols come with the instrument and...

Cite
Jonsson PV, Jensdottir AB, Gudmundsdottir H, et al. [Assessment of health and caring needs in nursing homes. The Resident Assessment Instrument, its development and some pilot study results.]. Laeknabladid. 1997;83(10):640-7
Jonsson, P. V., Jensdottir, A. B., Gudmundsdottir, H., Palsson, H., Hjaltadottir, I., Hardarson, O., & Sigurgeirsdottir, S. (1997). [Assessment of health and caring needs in nursing homes. The Resident Assessment Instrument, its development and some pilot study results.]. Laeknabladid, 83(10), 640-7.
Jonsson, P V, et al. "[Assessment of health and caring needs in nursing homes. The Resident Assessment Instrument, its development and some pilot study results.]." Laeknabladid vol. 83,10 (1997): 640-7.
Jonsson PV, Jensdottir AB, Gudmundsdottir H, Palsson H, Hjaltadottir I, Hardarson O, Sigurgeirsdottir S. [Assessment of health and caring needs in nursing homes. The Resident Assessment Instrument, its development and some pilot study results.]. Laeknabladid. 1997 Oct;83(10):640-7. Icelandic. PMID: 19679910.
Copy Download .nbib Format: NLM
Case-report: EBV driven lymphoproliferative disorder associated with Ruxolitinib.

BMC hematology

Pálmason R, Lindén O, Richter J.
PMID: 26167286
BMC Hematol. 2015 Jul 11;15:10. doi: 10.1186/s12878-015-0029-1. eCollection 2015.

BACKGROUND: Ruxolitinib, a novel inhibitor of Janus kinases 1 and 2, was recently approved for the treatment of myelofibrosis but, recently, attention has been drawn to potential side effects and especially opportunistic infections and virus reactivations. EBV reactivation has...

Cite
Pálmason R, Lindén O, Richter J. Case-report: EBV driven lymphoproliferative disorder associated with Ruxolitinib. BMC Hematol. 2015;15:10doi: 10.1186/s12878-015-0029-1.
Pálmason, R., Lindén, O., & Richter, J. (2015). Case-report: EBV driven lymphoproliferative disorder associated with Ruxolitinib. BMC hematology, 1510. https://doi.org/10.1186/s12878-015-0029-1
Pálmason, Róbert, et al. "Case-report: EBV driven lymphoproliferative disorder associated with Ruxolitinib." BMC hematology vol. 15 (2015): 10. doi: https://doi.org/10.1186/s12878-015-0029-1
Pálmason R, Lindén O, Richter J. Case-report: EBV driven lymphoproliferative disorder associated with Ruxolitinib. BMC Hematol. 2015 Jul 11;15:10. doi: 10.1186/s12878-015-0029-1. eCollection 2015. PMID: 26167286; PMCID: PMC4498562.
Copy Download .nbib Format: NLM
[Optimization of variables in photodynamic antifungal assays against Candida species].

Revista Argentina de microbiologia

Bulacio L, Ramadán S, Dalmaso H, Luque A, Sortino M.
PMID: 33648798
Rev Argent Microbiol. 2021 Feb 26; doi: 10.1016/j.ram.2020.12.006. Epub 2021 Feb 26.

Oral infections due to yeasts of the genus Candida are very common in patients with predisposing factors, such as physiological conditions or certain underlying diseases. Moreover, oral candidiasis can also evolve into disseminated forms. In this work, strains of...

Cite
Bulacio L, Ramadán S, Dalmaso H, et al. Optimización de variables en ensayos de actividad antifúngica fotodinámica frente a especies de Candida. [Optimization of variables in photodynamic antifungal assays against Candida species]. Rev Argent Microbiol. 2021;doi: 10.1016/j.ram.2020.12.006.
Bulacio, L., Ramadán, S., Dalmaso, H., Luque, A., & Sortino, M. (2021). Optimización de variables en ensayos de actividad antifúngica fotodinámica frente a especies de Candida. [Optimization of variables in photodynamic antifungal assays against Candida species]. Revista Argentina de microbiologia, . https://doi.org/10.1016/j.ram.2020.12.006
Bulacio, Lucía, et al. "Optimización de variables en ensayos de actividad antifúngica fotodinámica frente a especies de Candida." [Optimization of variables in photodynamic antifungal assays against Candida species]. Revista Argentina de microbiologia vol. (2021). doi: https://doi.org/10.1016/j.ram.2020.12.006
Bulacio L, Ramadán S, Dalmaso H, Luque A, Sortino M. Optimización de variables en ensayos de actividad antifúngica fotodinámica frente a especies de Candida. [Optimization of variables in photodynamic antifungal assays against Candida species]. Rev Argent Microbiol. 2021 Feb 26; doi: 10.1016/j.ram.2020.12.006. Epub 2021 Feb 26. Spanish. PMID: 33648798.
Copy Download .nbib Format: NLM
[Optimization of variables in photodynamic antifungal assays against Candida species].

Revista Argentina de microbiologia

Bulacio L, Ramadán S, Dalmaso H, Luque A, Sortino M.
PMID: 33648798
Rev Argent Microbiol. 2021 Oct-Dec;53(4):287-291. doi: 10.1016/j.ram.2020.12.006. Epub 2021 Feb 27.

Oral infections due to yeasts of the genus Candida are very common in patients with predisposing factors, such as physiological conditions or certain underlying diseases. Moreover, oral candidiasis can also evolve into disseminated forms. In this work, strains of...

Cite
Bulacio L, Ramadán S, Dalmaso H, et al. Optimización de variables en ensayos de actividad antifúngica fotodinámica frente a especies de Candida. [Optimization of variables in photodynamic antifungal assays against Candida species]. Rev Argent Microbiol. 2021;53(4):287-291doi: 10.1016/j.ram.2020.12.006.
Bulacio, L., Ramadán, S., Dalmaso, H., Luque, A., & Sortino, M. (2021). Optimización de variables en ensayos de actividad antifúngica fotodinámica frente a especies de Candida. [Optimization of variables in photodynamic antifungal assays against Candida species]. Revista Argentina de microbiologia, 53(4), 287-291. https://doi.org/10.1016/j.ram.2020.12.006
Bulacio, Lucía, et al. "Optimización de variables en ensayos de actividad antifúngica fotodinámica frente a especies de Candida." [Optimization of variables in photodynamic antifungal assays against Candida species]. Revista Argentina de microbiologia vol. 53,4 (2021): 287-291. doi: https://doi.org/10.1016/j.ram.2020.12.006
Bulacio L, Ramadán S, Dalmaso H, Luque A, Sortino M. Optimización de variables en ensayos de actividad antifúngica fotodinámica frente a especies de Candida. [Optimization of variables in photodynamic antifungal assays against Candida species]. Rev Argent Microbiol. 2021 Oct-Dec;53(4):287-291. doi: 10.1016/j.ram.2020.12.006. Epub 2021 Feb 27. Spanish. PMID: 33648798.
Copy Download .nbib Format: NLM
Showing 1 to 5 of 5 entries